SE7812911L - NEW ORGANIC ASSOCIATIONS - Google Patents

NEW ORGANIC ASSOCIATIONS

Info

Publication number
SE7812911L
SE7812911L SE7812911A SE7812911A SE7812911L SE 7812911 L SE7812911 L SE 7812911L SE 7812911 A SE7812911 A SE 7812911A SE 7812911 A SE7812911 A SE 7812911A SE 7812911 L SE7812911 L SE 7812911L
Authority
SE
Sweden
Prior art keywords
new organic
associations
organic associations
new
organic
Prior art date
Application number
SE7812911A
Other languages
Swedish (sv)
Other versions
SE436027B (en
Inventor
N S Bador
Original Assignee
Interx Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interx Research Corp filed Critical Interx Research Corp
Publication of SE7812911L publication Critical patent/SE7812911L/en
Publication of SE436027B publication Critical patent/SE436027B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/90Benzo [c] furans; Hydrogenated benzo [c] furans with an oxygen atom in position 1 and a nitrogen atom in position 3, or vice versa
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE7812911A 1977-12-16 1978-12-15 NEW ESTARS OF QUARTERLY AMMONIUM SALTS WITH ANTICOLINERG ANTI-SECRETARY EFFECT AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE SALTS SE436027B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86121077A 1977-12-16 1977-12-16

Publications (2)

Publication Number Publication Date
SE7812911L true SE7812911L (en) 1979-06-17
SE436027B SE436027B (en) 1984-11-05

Family

ID=25335183

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7812911A SE436027B (en) 1977-12-16 1978-12-15 NEW ESTARS OF QUARTERLY AMMONIUM SALTS WITH ANTICOLINERG ANTI-SECRETARY EFFECT AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE SALTS

Country Status (15)

Country Link
JP (1) JPS5498711A (en)
AR (1) AR222478A1 (en)
AT (1) AT366380B (en)
AU (1) AU531835B2 (en)
CA (1) CA1102345A (en)
DE (1) DE2854308A1 (en)
DK (1) DK534178A (en)
ES (1) ES476048A1 (en)
FR (1) FR2422624A1 (en)
GB (1) GB2010270B (en)
IE (1) IE48012B1 (en)
IT (1) IT1101735B (en)
NL (1) NL7812257A (en)
NO (1) NO148776C (en)
SE (1) SE436027B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3045055A1 (en) * 1980-11-29 1982-07-01 Celamerck Gmbh & Co Kg, 6507 Ingelheim HETEROCYCLIC COMPOUNDS
JPS5993075A (en) * 1982-11-18 1984-05-29 Shionogi & Co Ltd Preparation of 1-phthalidyl-5-fluorouracil derivative
US5008111A (en) * 1984-10-11 1991-04-16 Schering Corporation Physiological means of enhancing transdermal delivery of drugs
US4824676A (en) * 1984-10-11 1989-04-25 Schering Corporation Physiological means of enhancing transdermal delivery of drugs
FR2703046B1 (en) * 1993-03-26 1995-05-05 Poudres & Explosifs Ste Nale Process for the preparation of alpha-monohalogenated oxalates and haloglyoxalates and new alpha-monohalogenated oxalates and haloglyoxalates.
AUPN814496A0 (en) 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US5962505A (en) * 1998-08-31 1999-10-05 Bobrove; Arthur M. Method for treating hot flashes in humans
US6433003B1 (en) 1999-04-23 2002-08-13 Arthur M. Bobrove Method for treating hyperhidrosis in mammals
AR044134A1 (en) 2003-05-02 2005-08-24 Novartis Ag DERIVATIVES OF QUINUCLIDINE, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS.
WO2006128255A1 (en) 2005-06-03 2006-12-07 Acrux Dds Pty Ltd Method and composition for transdermal drug delivery
KR20080089461A (en) * 2005-12-30 2008-10-06 랜박시 래보러터리스 리미티드 Muscarinic receptor antagonists
DK2219603T3 (en) 2007-11-02 2014-09-01 Acrux Dds Pty Ltd TRANSDERMAL DELIVERY SYSTEM
JP6621329B2 (en) * 2012-10-05 2019-12-18 スファエラ ファーマ ピーティーイー リミテッド Novel compounds, their synthesis and their use
DE102013013397A1 (en) 2013-08-13 2015-03-12 Epinamics Gmbh Aerosol dispenser for transdermal pharmaceutical compositions
CN110041264A (en) * 2019-04-11 2019-07-23 贺州学院 A kind of adamantyl glyoxaline ion liquid and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL101555C (en) * 1955-03-19
BE798253A (en) * 1973-04-16 1973-10-16 Bekaert Sa Nv SEATING
US3998815A (en) * 1974-06-24 1976-12-21 Interx Research Corporation 1-hydrocarbonoyloxymethyl-3-carbamoyl or 3-carboethoxy-pyridinium salts

Also Published As

Publication number Publication date
DK534178A (en) 1979-06-17
GB2010270A (en) 1979-06-27
IE48012B1 (en) 1984-09-05
DE2854308A1 (en) 1979-06-21
NL7812257A (en) 1979-06-19
GB2010270B (en) 1982-10-20
NO148776B (en) 1983-09-05
AT366380B (en) 1982-04-13
FR2422624A1 (en) 1979-11-09
AU4264678A (en) 1979-06-21
SE436027B (en) 1984-11-05
IE782499L (en) 1979-06-16
JPS5498711A (en) 1979-08-03
NO784229L (en) 1979-06-19
IT7830735A0 (en) 1978-12-12
CA1102345A (en) 1981-06-02
ES476048A1 (en) 1979-11-01
AR222478A1 (en) 1981-05-29
AU531835B2 (en) 1983-09-08
NO148776C (en) 1983-12-14
FR2422624B1 (en) 1983-10-14
IT1101735B (en) 1985-10-07
ATA901478A (en) 1981-08-15

Similar Documents

Publication Publication Date Title
SE7802022L (en) CHINAZOLE ASSOCIATIONS
SE7805217L (en) TIAAZA ASSOCIATIONS
SE7805136L (en) POLYEN ASSOCIATIONS
SE7809035L (en) NEW HETEROCYCLIC ASSOCIATIONS
SE7804220L (en) CHEMICAL ASSOCIATIONS
SE7802867L (en) NEW 4-ACYLAMINO-PHENYL-ETHANOLAMINES
SE7807642L (en) NEW 1-ACYL-2-CYANAZIRIDINES
SE7812911L (en) NEW ORGANIC ASSOCIATIONS
FI781867A (en) ORGANIC FOERENINGAR
FI782628A (en) ORGANIC LOESNINGSMEDEL UTNYTTJANDE DELIGNIFIERINGS- OCH FOERSOCKRINGSFOERFARANDE FOER LIGNOCELLULOSAHALTIGA PLANTMATERIAL
SE7804244L (en) N-HETEROCYCLIC ASSOCIATIONS
FI781461A (en) FOERFARANDE FOER FRAMSTAELLNING AV NYA ALKYLENDIAMINDERIVAT
SE7807262L (en) NEW PHOSPHORUS ASSOCIATIONS
SE7804880L (en) ALCOXISILANDUBBLE CLUSTER ASSOCIATIONS
SE7801697L (en) 1-OXADETIACEFAM ASSOCIATIONS
FI773717A (en) NYA AMINOALKOXIFENYLDERIVATER
SE7810050L (en) NEW 7-AZABENSIMIDAZOLES
FI781674A (en) NYA FLUORIDERADE AMINOSYROR
SE7807554L (en) ORGANIC ASSOCIATIONS
FI781885A (en) ORGANIC FOERENINGAR
FI783805A (en) ORGANIC BELAEGGNINGSKOMPOSITIONER
SE7703948L (en) NEW ANIBACTERIAL ASSOCIATIONS
SE7808018L (en) NEW IMIDAZO-ISOKINOLIN DIONER
FI782228A (en) FOERFARANDE FOER FRAMSTAELLNING AV NYA BENSOPYRANDERIVAT
SE7703736L (en) ORGANIC ASSOCIATIONS